According to the research report, the global market for Nervous System Medications should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China Nervous System Medications market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Nervous System Medications market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, Anesthetic segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital Pharmacy has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Nervous System Medications include Pfizer, Teva, Novartis, AstraZeneca, Takeda, Johnson & Johnson, EliLilly, Otsuka and Merck, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive study of the global market for Nervous System Medications.
Key Takeaways and Highlights

(1) Global Nervous System Medications market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Nervous System Medications market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(3) China Nervous System Medications market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(4) Global Nervous System Medications segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Nervous System Medications segment by type and by application and regional segment by type and by application.

(6) Global major production regions of Nervous System Medications, capacity, production and trends.

(7) Nervous System Medications industry supply chain, upstream, midstream and downstream analysis.

Regional Breakdown: Analyzing Market Segments by Geography

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Segmenting by Type: Comprehensive Coverage and Analysis

Anesthetic

Painkiller

Psychostimulants

Antiepileptic Drugs

Anti-Parkinson Drugs

Others

Application-Based Segmentation: Unlocking Market Opportunities

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

In the Spotlight: A Closer Look at Market Players

Pfizer

Teva

Novartis

AstraZeneca

Takeda

Johnson & Johnson

EliLilly

Otsuka

Merck

Yangtze River Pharmaceutical

Humanwell Healthcare

CSPC-NBP Pharmaceutical

Nhwa Pharmaceutical

Qilu Pharma

1 Market Overview

1.1 Nervous System Medications Definition

1.2 Global Nervous System Medications Market Size and Forecast

1.2.1 By Revenue, Global Nervous System Medications Market Size, 2018-2029

1.2.2 By Sales Volume, Global Nervous System Medications Market Size, 2018-2029

1.2.3 Global Nervous System Medications Price Trend, 2018-2029

1.3 China Nervous System Medications Market Size and Forecast

1.3.1 By Revenue, China Nervous System Medications Market Size, 2018-2029

1.3.2 By Sales Volume, China Nervous System Medications Market Size, 2018-2029

1.3.3 China Nervous System Medications Price Trend, 2018-2029

1.4 China Percentage in Global Market

1.4.1 By Revenue, China Nervous System Medications Share in Global Market, 2018-2029

1.4.2 By Sales Volume, China Nervous System Medications Share in Global Market, 2018-2029

1.4.3 Nervous System Medications Market Size: China VS Global, 2018-2029

1.5 Nervous System Medications Market Dynamics

1.5.1 Nervous System Medications Market Drivers

1.5.2 Nervous System Medications Market Restraints

1.5.3 Nervous System Medications Industry Trends

1.5.4 Nervous System Medications Industry Policy

2 Global Competitive Landscape by Company

2.1 Global Nervous System Medications Revenue by Company, 2018-2023

2.2 Global Nervous System Medications Sales Volume by Company, 2018-2023

2.3 Global Nervous System Medications Price by Company, 2018-2023

2.4 Global Nervous System Medications Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global Nervous System Medications Concentration Ratio

2.6 Global Nervous System Medications Mergers & Acquisitions, Expansion Plans

2.7 Global Nervous System Medications Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China Nervous System Medications Revenue by Company, 2018-2023

3.2 China Nervous System Medications Sales Volume by Company, 2018-2023

3.3 China Nervous System Medications Nervous System Medications Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China Nervous System Medications Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)

3.5 Chinese Local Players, Nervous System Medications Domestic VS Export

3.6 China Market, Nervous System Medications Import & Export

3.6.1 China Market, Nervous System Medications Import & Export, 2018-2029

3.6.2 China Nervous System Medications Import & Export Trends

3.6.3 Main Sources of China Nervous System Medications Import

3.6.4 Export Destination of China Nervous System Medications

4 Nervous System Medications Production by Region

4.1 Global Nervous System Medications Capacity, Production and Capacity Utilization, 2018-2029

4.2 Global Geographic Distribution of Nervous System Medications Manufacturers

4.3 Global Major Manufacturers, Nervous System Medications Capacity Expansion and Future Plans

4.4 Global Nervous System Medications Capacity by Region

4.5 Global Nervous System Medications Production by Region

4.5.1 Global Nervous System Medications Production & Forecast by Region, 2018 VS 2022 VS 2029

4.5.2 Global Nervous System Medications Production by Region, 2018-2023

4.5.3 Global Nervous System Medications Production Market Share & Forecast by Region, 2018-2029

5 Industry Chain Analysis

5.1 Nervous System Medications Industry Chain

5.2 Nervous System Medications Upstream Analysis

5.2.1 Nervous System Medications Core Raw Materials

5.2.2 Main Manufacturers of Nervous System Medications Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Nervous System Medications Production Mode

5.6 Nervous System Medications Procurement Model

5.7 Nervous System Medications Industry Sales Model and Sales Channels

5.7.1 Nervous System Medications Sales Model

5.7.2 Nervous System Medications Typical Distributors

6 Sights by Type

6.1 Nervous System Medications Classification

6.1.1 Anesthetic

6.1.2 Painkiller

6.1.3 Psychostimulants

6.1.4 Antiepileptic Drugs

6.1.5 Anti-Parkinson Drugs

6.1.6 Others

6.2 By Type, Global Nervous System Medications Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Type, Global Nervous System Medications Revenue, 2018-2029

6.4 By Type, Global Nervous System Medications Sales Volume, 2018-2029

6.5 By Type, Global Nervous System Medications Price, 2018-2029

7 Sights by Application

7.1 Nervous System Medications Segment by Application

7.1.1 Hospital Pharmacy

7.1.2 Retail Pharmacy

7.1.3 Online Pharmacy

7.2 By Application, Global Nervous System Medications Market Size & CAGR, 2018 VS 2022 VS 2029

7.3 By Application, Global Nervous System Medications Revenue, 2018-2029

7.4 By Application, Global Nervous System Medications Sales Volume, 2018-2029

7.5 By Application, Global Nervous System Medications Price, 2018-2029

8 Sales Sights by Region

8.1 By Region, Global Nervous System Medications Market Size, 2018 VS 2022 VS 2029

8.2 By Region, Global Nervous System Medications Revenue, 2018-2029

8.3 By Region, Global Nervous System Medications Sales Volume, 2018-2029

8.4 North America

8.4.1 North America Nervous System Medications Market Size & Forecasts, 2018-2029

8.4.2 By Country, North America Nervous System Medications Market Size Market Share

8.5 Europe

8.5.1 Europe Nervous System Medications Market Size & Forecasts, 2018-2029

8.5.2 By Country, Europe Nervous System Medications Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Nervous System Medications Market Size & Forecasts, 2018-2029

8.6.2 By Country/Region, Asia Pacific Nervous System Medications Market Size Market Share

8.7 South America

8.7.1 South America Nervous System Medications Market Size & Forecasts, 2018-2029

8.7.2 By Country, South America Nervous System Medications Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Nervous System Medications Market Size & CAGR，2018 VS 2022 VS 2029

9.2 By Country, Global Nervous System Medications Revenue, 2018-2029

9.3 By Country, Global Nervous System Medications Sales Volume, 2018-2029

9.4 U.S.

9.4.1 U.S. Nervous System Medications Market Size, 2018-2029

9.4.2 By Company, U.S. Nervous System Medications Sales Volume Market Share, 2022

9.4.3 By Type, U.S. Nervous System Medications Market Size, Share, 2022 VS 2029

9.4.4 By Application, U.S. Nervous System Medications Market Size, Share, 2022 VS 2029

9.5 Europe

9.5.1 Europe Nervous System Medications Market Size, 2018-2029

9.5.2 By Company, Europe Nervous System Medications Sales Volume Market Share, 2022

9.5.3 By Type, Europe Nervous System Medications Market Size, Share, 2022 VS 2029

9.5.4 By Application, Europe Nervous System Medications Market Size, Share, 2022 VS 2029

9.6 China

9.6.1 China Nervous System Medications Market Size, 2018-2029

9.6.2 By Company, China Nervous System Medications Sales Volume Market Share, 2022

9.6.3 By Type, China Nervous System Medications Market Size, Share, 2022 VS 2029

9.6.4 By Application, China Nervous System Medications Market Size, Share, 2022 VS 2029

9.7 Japan

9.7.1 Japan Nervous System Medications Market Size, 2018-2029

9.7.2 By Company, Japan Nervous System Medications Sales Volume Market Share, 2022

9.7.3 By Type, Japan Nervous System Medications Market Size, Share, 2022 VS 2029

9.7.4 By Application, Japan Nervous System Medications Market Size, Share, 2022 VS 2029

9.8 South Korea

9.8.1 South Korea Nervous System Medications Market Size, 2018-2029

9.8.2 By Company, South Korea Nervous System Medications Sales Volume Market Share, 2022

9.8.3 By Type, South Korea Nervous System Medications Market Size, Share, 2022 VS 2029

9.8.4 By Application, South Korea Nervous System Medications Market Size, Share, 2022 VS 2029

9.9 Southeast Asia

9.9.1 Southeast Asia Nervous System Medications Market Size, 2018-2029

9.9.2 By Company, Southeast Asia Nervous System Medications Sales Volume Market Share, 2022

9.9.3 By Type, Southeast Asia Nervous System Medications Market Size, Share, 2022 VS 2029

9.9.4 By Application, Southeast Asia Nervous System Medications Market Size, Share, 2022 VS 2029

9.10 India

9.10.1 India Nervous System Medications Market Size, 2018-2029

9.10.2 By Company, India Nervous System Medications Sales Volume Market Share, 2022

9.10.3 By Type, India Nervous System Medications Market Size, Share, 2022 VS 2029

9.10.4 By Application, India Nervous System Medications Market Size, Share, 2022 VS 2029

9.11 Middle East & Asia

9.11.1 Middle East & Asia Nervous System Medications Market Size, 2018-2029

9.11.2 By Company, Middle East & Asia Nervous System Medications Sales Volume Market Share, 2022

9.11.3 By Type, Middle East & Asia Nervous System Medications Market Size, Share, 2022 VS 2029

9.11.4 By Application, Middle East & Asia Nervous System Medications Market Size, Share, 2022 VS 2029

10 Manufacturers Profile

10.1 Pfizer

10.1.1 Pfizer Company Information, Head Office, Market Area and Industry Position

10.1.2 Pfizer Nervous System Medications Models, Specifications and Application

10.1.3 Pfizer Nervous System Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.1.4 Pfizer Company Profile and Main Business

10.1.5 Pfizer Recent Developments

10.2 Teva

10.2.1 Teva Company Information, Head Office, Market Area and Industry Position

10.2.2 Teva Nervous System Medications Models, Specifications and Application

10.2.3 Teva Nervous System Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.2.4 Teva Company Profile and Main Business

10.2.5 Teva Recent Developments

10.3 Novartis

10.3.1 Novartis Company Information, Head Office, Market Area and Industry Position

10.3.2 Novartis Nervous System Medications Models, Specifications and Application

10.3.3 Novartis Nervous System Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.3.4 Novartis Company Profile and Main Business

10.3.5 Novartis Recent Developments

10.4 AstraZeneca

10.4.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position

10.4.2 AstraZeneca Nervous System Medications Models, Specifications and Application

10.4.3 AstraZeneca Nervous System Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.4.4 AstraZeneca Company Profile and Main Business

10.4.5 AstraZeneca Recent Developments

10.5 Takeda

10.5.1 Takeda Company Information, Head Office, Market Area and Industry Position

10.5.2 Takeda Nervous System Medications Models, Specifications and Application

10.5.3 Takeda Nervous System Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.5.4 Takeda Company Profile and Main Business

10.5.5 Takeda Recent Developments

10.6 Johnson & Johnson

10.6.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position

10.6.2 Johnson & Johnson Nervous System Medications Models, Specifications and Application

10.6.3 Johnson & Johnson Nervous System Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.6.4 Johnson & Johnson Company Profile and Main Business

10.6.5 Johnson & Johnson Recent Developments

10.7 EliLilly

10.7.1 EliLilly Company Information, Head Office, Market Area and Industry Position

10.7.2 EliLilly Nervous System Medications Models, Specifications and Application

10.7.3 EliLilly Nervous System Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.7.4 EliLilly Company Profile and Main Business

10.7.5 EliLilly Recent Developments

10.8 Otsuka

10.8.1 Otsuka Company Information, Head Office, Market Area and Industry Position

10.8.2 Otsuka Nervous System Medications Models, Specifications and Application

10.8.3 Otsuka Nervous System Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.8.4 Otsuka Company Profile and Main Business

10.8.5 Otsuka Recent Developments

10.9 Merck

10.9.1 Merck Company Information, Head Office, Market Area and Industry Position

10.9.2 Merck Nervous System Medications Models, Specifications and Application

10.9.3 Merck Nervous System Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.9.4 Merck Company Profile and Main Business

10.9.5 Merck Recent Developments

10.10 Yangtze River Pharmaceutical

10.10.1 Yangtze River Pharmaceutical Company Information, Head Office, Market Area and Industry Position

10.10.2 Yangtze River Pharmaceutical Nervous System Medications Models, Specifications and Application

10.10.3 Yangtze River Pharmaceutical Nervous System Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.10.4 Yangtze River Pharmaceutical Company Profile and Main Business

10.10.5 Yangtze River Pharmaceutical Recent Developments

10.11 Humanwell Healthcare

10.11.1 Humanwell Healthcare Company Information, Head Office, Market Area and Industry Position

10.11.2 Humanwell Healthcare Nervous System Medications Models, Specifications and Application

10.11.3 Humanwell Healthcare Nervous System Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.11.4 Humanwell Healthcare Company Profile and Main Business

10.11.5 Humanwell Healthcare Recent Developments

10.12 CSPC-NBP Pharmaceutical

10.12.1 CSPC-NBP Pharmaceutical Company Information, Head Office, Market Area and Industry Position

10.12.2 CSPC-NBP Pharmaceutical Nervous System Medications Models, Specifications and Application

10.12.3 CSPC-NBP Pharmaceutical Nervous System Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.12.4 CSPC-NBP Pharmaceutical Company Profile and Main Business

10.12.5 CSPC-NBP Pharmaceutical Recent Developments

10.13 Nhwa Pharmaceutical

10.13.1 Nhwa Pharmaceutical Company Information, Head Office, Market Area and Industry Position

10.13.2 Nhwa Pharmaceutical Nervous System Medications Models, Specifications and Application

10.13.3 Nhwa Pharmaceutical Nervous System Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.13.4 Nhwa Pharmaceutical Company Profile and Main Business

10.13.5 Nhwa Pharmaceutical Recent Developments

10.14 Qilu Pharma

10.14.1 Qilu Pharma Company Information, Head Office, Market Area and Industry Position

10.14.2 Qilu Pharma Nervous System Medications Models, Specifications and Application

10.14.3 Qilu Pharma Nervous System Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.14.4 Qilu Pharma Company Profile and Main Business

10.14.5 Qilu Pharma Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Nervous System Medications Market Size & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Nervous System Medications Market Restraints

Table 3. Nervous System Medications Market Trends

Table 4. Nervous System Medications Industry Policy

Table 5. Global Nervous System Medications Revenue by Company, 2018-2023, US$ million

Table 6. Global Nervous System Medications Revenue Market Share by Company, 2018-2023

Table 7. Global Nervous System Medications Sales Volume by Company, 2018-2023, (K Units)

Table 8. Global Nervous System Medications Sales Volume Market Share by Company, 2018-2023

Table 9. Global Nervous System Medications Price by Company, 2018-2023, (US$/Unit)

Table 10. Global Nervous System Medications Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Nervous System Medications Mergers & Acquisitions, Expansion Plans

Table 12. Global Nervous System Medications Manufacturers Product Type

Table 13. China Nervous System Medications Revenue by Company, 2018-2023, US$ million

Table 14. China Nervous System Medications Revenue Market Share by Company, 2018-2023

Table 15. China Nervous System Medications Sales Volume by Company, 2018-2023, (K Units)

Table 16. China Nervous System Medications Sales Volume Market Share by Company, 2018-2023

Table 17. China Market, Nervous System Medications Production, Sales, Import and Export, 2018-2029, (K Units)

Table 18. China Nervous System Medications Import & Export Trends

Table 19. Main Sources of China Nervous System Medications Import

Table 20. Export Destination of China Nervous System Medications

Table 21. Global Headquarters and Manufacturing Base of Nervous System Medications Manufacturers

Table 22. Global Major Manufacturers, Nervous System Medications Capacity Expansion and Future Plans

Table 23. Global Nervous System Medications Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 24. Global Nervous System Medications Production by Region, 2018-2023, (K Units)

Table 25. Global Nervous System Medications Production Forecast by Region, 2023-2029, (K Units)

Table 26. Global Key Players of Nervous System Medications Upstream (Raw Materials)

Table 27. Global Nervous System Medications Typical Customers

Table 28. Nervous System Medications Typical Distributors

Table 29. By Type, Global Nervous System Medications Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Application, Global Nervous System Medications Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 31. By Region, Global Nervous System Medications Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 32. By Region, Global Nervous System Medications Revenue, 2018-2029, US$ Million

Table 33. By Region, Global Nervous System Medications Sales Volume, 2018-2029, (K Units)

Table 34. By Country, Global Nervous System Medications Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 35. By Country, Global Nervous System Medications Revenue, 2018-2029, US$ Million

Table 36. By Country, Global Nervous System Medications Revenue Market Share, 2018-2029

Table 37. By Country, Global Nervous System Medications Sales Volume, 2018-2029, (K Units)

Table 38. By Country, Global Nervous System Medications Sales Volume Market Share, 2018-2029

Table 39. Pfizer Company Information, Head Office, Market Area and Industry Position

Table 40. Pfizer Nervous System Medications Models, Specifications and Application

Table 41. Pfizer Nervous System Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. Pfizer Company Profile and Main Business

Table 43. Pfizer Recent Developments

Table 44. Teva Company Information, Head Office, Market Area and Industry Position

Table 45. Teva Nervous System Medications Models, Specifications and Application

Table 46. Teva Nervous System Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. Teva Company Profile and Main Business

Table 48. Teva Recent Developments

Table 49. Novartis Company Information, Head Office, Market Area and Industry Position

Table 50. Novartis Nervous System Medications Models, Specifications and Application

Table 51. Novartis Nervous System Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. Novartis Company Profile and Main Business

Table 53. Novartis Recent Developments

Table 54. AstraZeneca Company Information, Head Office, Market Area and Industry Position

Table 55. AstraZeneca Nervous System Medications Models, Specifications and Application

Table 56. AstraZeneca Nervous System Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. AstraZeneca Company Profile and Main Business

Table 58. AstraZeneca Recent Developments

Table 59. Takeda Company Information, Head Office, Market Area and Industry Position

Table 60. Takeda Nervous System Medications Models, Specifications and Application

Table 61. Takeda Nervous System Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. Takeda Company Profile and Main Business

Table 63. Takeda Recent Developments

Table 64. Johnson & Johnson Company Information, Head Office, Market Area and Industry Position

Table 65. Johnson & Johnson Nervous System Medications Models, Specifications and Application

Table 66. Johnson & Johnson Nervous System Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. Johnson & Johnson Company Profile and Main Business

Table 68. Johnson & Johnson Recent Developments

Table 69. EliLilly Company Information, Head Office, Market Area and Industry Position

Table 70. EliLilly Nervous System Medications Models, Specifications and Application

Table 71. EliLilly Nervous System Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. EliLilly Company Profile and Main Business

Table 73. EliLilly Recent Developments

Table 74. Otsuka Company Information, Head Office, Market Area and Industry Position

Table 75. Otsuka Nervous System Medications Models, Specifications and Application

Table 76. Otsuka Nervous System Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. Otsuka Company Profile and Main Business

Table 78. Otsuka Recent Developments

Table 79. Merck Company Information, Head Office, Market Area and Industry Position

Table 80. Merck Nervous System Medications Models, Specifications and Application

Table 81. Merck Nervous System Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 82. Merck Company Profile and Main Business

Table 83. Merck Recent Developments

Table 84. Yangtze River Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 85. Yangtze River Pharmaceutical Nervous System Medications Models, Specifications and Application

Table 86. Yangtze River Pharmaceutical Nervous System Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 87. Yangtze River Pharmaceutical Company Profile and Main Business

Table 88. Yangtze River Pharmaceutical Recent Developments

Table 89. Humanwell Healthcare Company Information, Head Office, Market Area and Industry Position

Table 90. Humanwell Healthcare Nervous System Medications Models, Specifications and Application

Table 91. Humanwell Healthcare Nervous System Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 92. Humanwell Healthcare Company Profile and Main Business

Table 93. Humanwell Healthcare Recent Developments

Table 94. CSPC-NBP Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 95. CSPC-NBP Pharmaceutical Nervous System Medications Models, Specifications and Application

Table 96. CSPC-NBP Pharmaceutical Nervous System Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 97. CSPC-NBP Pharmaceutical Company Profile and Main Business

Table 98. CSPC-NBP Pharmaceutical Recent Developments

Table 99. Nhwa Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 100. Nhwa Pharmaceutical Nervous System Medications Models, Specifications and Application

Table 101. Nhwa Pharmaceutical Nervous System Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 102. Nhwa Pharmaceutical Company Profile and Main Business

Table 103. Nhwa Pharmaceutical Recent Developments

Table 104. Qilu Pharma Company Information, Head Office, Market Area and Industry Position

Table 105. Qilu Pharma Nervous System Medications Models, Specifications and Application

Table 106. Qilu Pharma Nervous System Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 107. Qilu Pharma Company Profile and Main Business

Table 108. Qilu Pharma Recent Developments

List of Figure

Figure 1. Nervous System Medications Picture

Figure 2. By Revenue, Global Nervous System Medications Market Size and Forecast, 2018-2029, US$ Million

Figure 3. By Sales Volume, Global Nervous System Medications Market Size and Forecast, 2018-2029, (K Units)

Figure 4. Global Nervous System Medications Price Trend, 2018-2029, (US$/Unit)

Figure 5. By Revenue, China Nervous System Medications Market Size and Forecast, 2018-2029, US$ million

Figure 6. By Sales Volume, China Nervous System Medications Market Size and Forecast, 2018-2029, (K Units)

Figure 7. China Nervous System Medications Price Trend, 2018-2029 (US$/Unit)

Figure 8. By Revenue, China Nervous System Medications Share of Global Market, 2018-2029

Figure 9. By Sales Volume, China Nervous System Medications Share of Global Market, 2018-2029

Figure 10. Global Nervous System Medications Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Nervous System Medications Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Nervous System Medications Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Nervous System Medications Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Nervous System Medications Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 15. Chinese Local Players, Proportion of Nervous System Medications Domestic VS Export, 2022

Figure 16. Global Nervous System Medications Capacity, Production and Capacity Utilization, 2018-2029

Figure 17. Global Nervous System Medications Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Nervous System Medications Production Market Share & Forecast by Region, 2018-2029

Figure 19. Nervous System Medications Industry Chain

Figure 20. Nervous System Medications Procurement Model

Figure 21. Nervous System Medications Sales Model

Figure 22. Nervous System Medications Sales Channels, Direct Sales and Distribution

Figure 23. Anesthetic

Figure 24. Painkiller

Figure 25. Psychostimulants

Figure 26. Antiepileptic Drugs

Figure 27. Anti-Parkinson Drugs

Figure 28. Others

Figure 29. By Type, Global Nervous System Medications Revenue, 2018-2029, US$ Million

Figure 30. By Type, Global Nervous System Medications Revenue Market Share, 2018-2029

Figure 31. By Type, Global Nervous System Medications Sales Volume, 2018-2029, (K Units)

Figure 32. By Type, Global Nervous System Medications Sales Volume Market Share, 2018-2029

Figure 33. By Type, Global Nervous System Medications Price, 2018-2029, (US$/Unit)

Figure 34. Hospital Pharmacy

Figure 35. Retail Pharmacy

Figure 36. Online Pharmacy

Figure 37. By Application, Global Nervous System Medications Revenue, 2018-2029, US$ Million

Figure 38. By Application, Global Nervous System Medications Revenue Market Share, 2018-2029

Figure 39. By Application, Global Nervous System Medications Sales Volume, 2018-2029, (K Units)

Figure 40. By Application, Global Nervous System Medications Sales Volume Market Share, 2018-2029

Figure 41. By Application, Global Nervous System Medications Price, 2018-2029, (US$/Unit)

Figure 42. By Region, Global Nervous System Medications Revenue Market Share, 2018-2029

Figure 43. By Region, Global Nervous System Medications Sales Volume Market Share, 2018-2029

Figure 44. North America Nervous System Medications Revenue & Forecasts, 2018-2029, US$ Million

Figure 45. By Country, North America Nervous System Medications Revenue Market Share, 2022

Figure 46. Europe Nervous System Medications Revenue & Forecasts, 2018-2029, US$ Million

Figure 47. By Country, Europe Nervous System Medications Revenue Market Share, 2022

Figure 48. Asia Pacific Nervous System Medications Revenue & Forecasts, 2018-2029, US$ Million

Figure 49. By Country/Region, Asia Pacific Nervous System Medications Revenue Market Share, 2022

Figure 50. South America Nervous System Medications Revenue & Forecasts, 2018-2029, US$ Million

Figure 51. By Country, South America Nervous System Medications Revenue Market Share, 2022

Figure 52. Middle East & Africa Nervous System Medications Revenue & Forecasts, 2018-2029, US$ Million

Figure 53. U.S. Nervous System Medications Sales Volume, 2018-2029, (K Units)

Figure 54. By Company, U.S. Nervous System Medications Market Share, 2022

Figure 55. By Type, U.S. Nervous System Medications Sales Volume Market Share, 2022 VS 2029

Figure 56. By Application, U.S. Nervous System Medications Sales Volume Market Share, 2022 VS 2029

Figure 57. Europe Nervous System Medications Sales Volume, 2018-2029, (K Units)

Figure 58. By Company, Europe Nervous System Medications Market Share, 2022

Figure 59. By Type, Europe Nervous System Medications Sales Volume Market Share, 2022 VS 2029

Figure 60. By Application, Europe Nervous System Medications Sales Volume Market Share, 2022 VS 2029

Figure 61. China Nervous System Medications Sales Volume, 2018-2029, (K Units)

Figure 62. By Company, China Nervous System Medications Market Share, 2022

Figure 63. By Type, China Nervous System Medications Sales Volume Market Share, 2022 VS 2029

Figure 64. By Application, China Nervous System Medications Sales Volume Market Share, 2022 VS 2029

Figure 65. Japan Nervous System Medications Sales Volume, 2018-2029, (K Units)

Figure 66. By Company, Japan Nervous System Medications Market Share, 2022

Figure 67. By Type, Japan Nervous System Medications Sales Volume Market Share, 2022 VS 2029

Figure 68. By Application, Japan Nervous System Medications Sales Volume Market Share, 2022 VS 2029

Figure 69. South Korea Nervous System Medications Sales Volume, 2018-2029, (K Units)

Figure 70. By Company, South Korea Nervous System Medications Market Share, 2022

Figure 71. By Type, South Korea Nervous System Medications Sales Volume Market Share, 2022 VS 2029

Figure 72. By Application, South Korea Nervous System Medications Sales Volume Market Share, 2022 VS 2029

Figure 73. Southeast Asia Nervous System Medications Sales Volume, 2018-2029, (K Units)

Figure 74. By Company, Southeast Asia Nervous System Medications Market Share, 2022

Figure 75. By Type, Southeast Asia Nervous System Medications Sales Volume Market Share, 2022 VS 2029

Figure 76. By Application, Southeast Asia Nervous System Medications Sales Volume Market Share, 2022 VS 2029

Figure 77. India Nervous System Medications Sales Volume, 2018-2029, (K Units)

Figure 78. By Company, India Nervous System Medications Market Share, 2022

Figure 79. By Type, India Nervous System Medications Sales Volume Market Share, 2022 VS 2029

Figure 80. By Application, India Nervous System Medications Sales Volume Market Share, 2022 VS 2029

Figure 81. Middle East & Asia Nervous System Medications Sales Volume, 2018-2029, (K Units)

Figure 82. By Company, Middle East & Asia Nervous System Medications Market Share, 2022

Figure 83. By Type, Middle East & Asia Nervous System Medications Sales Volume Market Share, 2022 VS 2029

Figure 84. By Application, Middle East & Asia Nervous System Medications Sales Volume Market Share, 2022 VS 2029

Figure 85. Research Methodology

Figure 86. Breakdown of Primary Interviews

Figure 87. Bottom-up Approaches

Figure 88. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)